Home › Free Stock Grades › RXST
RxSight, Inc. (RXST) Stock Grade
RXST · Healthcare
C
Market Cap
$429.1M
P/E Ratio
—
Revenue Growth (YoY)
-3.9%
Net Margin
-29.0%
Return on Equity
—
Dividend Yield
None
About RxSight, Inc.'s fundamentals
RxSight is a medical device company with a market capitalization of $429.1 million that reported a net loss in its latest annual statement, reflecting a negative net margin of -29.0%. The company experienced a slight revenue contraction of 3.9% year-over-year, indicating declining sales in its current operating period. With no dividend yield and the absence of positive profitability metrics, RxSight remains in a loss-making position as it continues its operations in the medical devices sector.